Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Apr 05, 2021 5:44pm
111 Views
Post# 32938969

RE:RE:RE:RE:So AVRT

RE:RE:RE:RE:So AVRTIchor already has it on their site and should be able to start doing tests this month.  I like Ichor and the guy that runs it but its small potatoes.

The key all along has been Mercer.

A few small companies with 1 or two offices is good but it wont help us to replace covid test demand numbers.

They have been hiring people and expanding the lab so why is that?

1. Is it only for covid numbers (again they had a 1000 test per day capacity months ago so I dont think thats it cause they arent maxed out doing covid tests
2. Is it for a total guess in numbers of cancer tests via this health clinic purchase?  I dont see how that can be the case.  Even if every one of Care's patients 3000 took a test its not enough to justify the employee increase.
3. Is it for a combo of covid and these health care clincs?  Maybe but again what happens when covid tests go down.  Surely they are planing for the future of that.  Maybe they think by then cancer tests will be higher and this is a straight up gamble?
4. Are they confident they will actually get a large health care provider?

Basically what do we know for sure?

Answer = ???
<< Previous
Bullboard Posts
Next >>